Drug reference
Surgical anaesthesia ▶BY LUMBAR EPIDURAL, OR BY LOCAL INFILTRATION, OR BY CAUDAL EPIDURAL ▶Adult: (consult product literature) Acute pain management ▶BY LUMBAR EPIDURAL, OR BY LOCAL INFILTRATION ▶Adult: (consult product literature)
PDF page 1442
CAUTIONS, FURTHER INFORMATION In patients with severe hypertension or unstable cardiac rhythm, the use of adrenaline with a local anaesthetic may be hazardous. For these patients an anaesthetic without adrenaline should be used.
PDF page 1442
→Appendix 1: anaesthetics, local. sympathomimetics, vasoconstrictor
PDF page 1442
There can be variation in the licensing of different medicines containing the same drug. Solution for injection ▶Bupivacaine with adrenaline (Non-proprietary) Adrenaline (as Adrenaline acid tartrate) 5 microgram per 1 ml, Bupivacaine hydrochloride 2.5 mg per 1 ml Bupivacaine 25mg/10ml (0.25%) /Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | 10 ampoule P £46.00 DT = £46.00 Adrenaline (as Adrenaline acid tartrate) 5 microgram per 1 ml, Bupivacaine hydrochloride anhydrous 2.5 mg per 1 ml Carbostesin-adrenaline 0.25% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules | 1 ampoule P s Carbostesin-adrenaline 0.25% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules | 1 ampoule P s Adrenaline (as Adrenaline acid tartrate) 5 microgram per 1 ml, Bupivacaine hydrochloride 5 mg per 1 ml Bupivacaine 50mg/10ml (0.5%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules | 10 ampoule P £51.75 DT = £51.75 Adrenaline (as Adrenaline acid tartrate) 5 microgram per 1 ml, Bupivacaine hydrochloride anhydrous 5 mg per 1 ml Carbostesin- adrenaline 0.5% / 25micrograms/5ml (1 in 200,000) solution for injection ampoules | 1 ampoule P s Carbostesin-adrenaline 0.5% / 100micrograms/20ml (1 in 200,000) solution for injection ampoules | 1 ampoule P s
PDF page 1443
(consult product literature)
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1442
(consult product literature)
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1442
